small molecule

DILTIAZEM HYDROCHLORIDE

DILTIAZEM HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyDR REDDYS LABORATORIES SA

Drug detail

Brand nameDILTIAZEM HYDROCHLORIDE
Active ingredientDILTIAZEM HYDROCHLORIDE
Strength120MG
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalMay 2022
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.